You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
研報掘金丨信達證券:健康元上半年呼吸製劑快速放量,研發品種迎來上市收穫期
格隆匯 09-07 13:26

信達證券研報指出,健康元(600380.SH)上半年呼吸製劑快速放量,中藥製劑增長亮眼。呼吸製劑多款產品獲批上市或處於NDA階段,研發進入收穫期健康元(不含麗珠集團、麗珠單抗)實現營業收入21.94億元(yoy-7.48%)。研發品種迎來上市收穫期:2023年7月,富馬酸福莫特羅吸入溶液獲批上市,馬來酸茚達特羅吸入粉霧劑、丙酸氟替卡松霧化吸入用混懸液、沙美特羅替卡松吸入粉霧劑處於NDA階段。上半年公司加快重點呼吸品種尤其是妥布黴素吸入溶液開發上量工作,新增開發二級以上醫院559家,呼吸品種實現覆蓋二級以上醫院3800多家。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account